HomeCompareRWLK vs NOBL

RWLK vs NOBL: Dividend Comparison 2026

RWLK yields 190.46% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RWLK wins by $90.18M in total portfolio value
10 years
RWLK
RWLK
● Live price
190.46%
Share price
$1.05
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$90.21M
Annual income
$44,374,134.97
Full RWLK calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — RWLK vs NOBL

📍 RWLK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRWLKNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RWLK + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RWLK pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RWLK
Annual income on $10K today (after 15% tax)
$16,188.93/yr
After 10yr DRIP, annual income (after tax)
$37,718,014.72/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, RWLK beats the other by $37,717,805.46/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RWLK + NOBL for your $10,000?

RWLK: 50%NOBL: 50%
100% NOBL50/50100% RWLK
Portfolio after 10yr
$45.11M
Annual income
$22,187,190.57/yr
Blended yield
49.18%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on RWLK right now

RWLK
Analyst Ratings
4
Buy
1
Sell
Consensus: Buy
Price Target
$3.00
+185.7% upside vs current
Range: $3.00 — $3.00
Altman Z
-3.3
Piotroski
4/9
NOBL
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RWLK buys
0
NOBL buys
0
No recent congressional trades found for RWLK or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRWLKNOBL
Forward yield190.46%2.14%
Annual dividend / share$2.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$90.21M$22.8K
Annual income after 10y$44,374,134.97$246.19
Total dividends collected$84.78M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: RWLK vs NOBL ($10,000, DRIP)

YearRWLK PortfolioRWLK Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$29,746$19,045.81$10,914$214.34+$18.8KRWLK
2$84,775$52,946.99$11,897$218.63+$72.9KRWLK
3$231,735$141,026.13$12,952$222.72+$218.8KRWLK
4$608,237$360,280.17$14,086$226.62+$594.2KRWLK
5$1,534,579$883,765.58$15,302$230.33+$1.52MRWLK
6$3,725,866$2,083,865.86$16,607$233.85+$3.71MRWLK
7$8,715,181$4,728,505.05$18,007$237.18+$8.70MRWLK
8$19,662,120$10,336,876.26$19,508$240.35+$19.64MRWLK
9$42,833,599$21,795,129.93$21,116$243.35+$42.81MRWLK
10$90,206,085$44,374,134.97$22,841$246.19+$90.18MRWLK

RWLK vs NOBL: Complete Analysis 2026

RWLKStock

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes robotic exoskeletons for individuals with mobility impairments or other medical conditions in the United States, Europe, the Asia-Pacific, and Africa. The company offers ReWalk Personal and ReWalk Rehabilitation for spinal cord injuries and everyday use by paraplegic individuals at home and in communities; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke in the clinical rehabilitation environment; and MyoCycle and MediTouch tutor movement biofeedback devices for use at home or in clinic. It markets and sells its products directly to third party payers; institutions, including rehabilitation centers; and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Ilit, Israel.

Full RWLK Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this RWLK vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RWLK vs SCHDRWLK vs JEPIRWLK vs ORWLK vs KORWLK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.